Literature DB >> 27991888

Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant.

B K Watkins1, J Horan1, B Storer2,3, P J Martin2,4, P A Carpenter2,5, M E D Flowers2,4.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27991888     DOI： 10.1038/bmt.2016.328

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

1.  National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery.

Authors:  Navneet S Majhail; Lih-Wen Mau; Pintip Chitphakdithai; Tammy Payton; Michael Eckrich; Steven Joffe; Stephanie J Lee; Charles F LeMaistre; Jennifer LeRademacher; Fausto Loberiza; Brent Logan; Susan K Parsons; Ramona Repaczki-Jones; Pam Robinett; J Douglas Rizzo; Elizabeth Murphy; Ellen M Denzen
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-31       Impact factor: 5.742

2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

3.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

4.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

Authors:  Mary E D Flowers; Yoshihiro Inamoto; Paul A Carpenter; Stephanie J Lee; Hans-Peter Kiem; Effie W Petersdorf; Shalini E Pereira; Richard A Nash; Marco Mielcarek; Matthew L Fero; Edus H Warren; Jean E Sanders; Rainer F Storb; Frederick R Appelbaum; Barry E Storer; Paul J Martin
Journal:  Blood       Date:  2011-01-24       Impact factor: 22.113

5.  Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.

Authors:  Mary Eapen; Mary M Horowitz; John P Klein; Richard E Champlin; Fausto R Loberiza; Olle Ringdén; John E Wagner
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

6.  Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome.

Authors:  Marco Zecca; Arcangelo Prete; Roberto Rondelli; Edoardo Lanino; Adriana Balduzzi; Chiara Messina; Franca Fagioli; Fulvio Porta; Claudio Favre; Andrea Pession; Franco Locatelli
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113
  6 in total
  6 in total

Review 1.  How I treat sickle cell disease with hematopoietic cell transplantation.

Authors:  Elizabeth O Stenger; Shalini Shenoy; Lakshmanan Krishnamurti
Journal:  Blood       Date:  2019-12-19       Impact factor: 22.113

2.  Hematopoietic cell transplantation for sickle cell disease: updates and future directions.

Authors:  Lakshmanan Krishnamurti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

3.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.

Authors:  Joseph Pidala; Carrie Kitko; Stephanie J Lee; Paul Carpenter; Geoffrey D E Cuvelier; Shernan Holtan; Mary E Flowers; Corey Cutler; Madan Jagasia; Ted Gooley; Joycelynne Palmer; Tim Randolph; John E Levine; Francis Ayuk; Fiona Dignan; Helene Schoemans; Eric Tkaczyk; Nosha Farhadfar; Anita Lawitschka; Kirk R Schultz; Paul J Martin; Stefanie Sarantopoulos; Yoshihiro Inamoto; Gerard Socie; Daniel Wolff; Bruce Blazar; Hildegard Greinix; Sophie Paczesny; Steven Pavletic; Geoffrey Hill
Journal:  Transplant Cell Ther       Date:  2021-04-06

Review 4.  Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies.

Authors:  Emma C Morris; Michael H Albert
Journal:  Front Pediatr       Date:  2019-10-24       Impact factor: 3.418

Review 5.  Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions.

Authors:  Asaf Yanir; Ansgar Schulz; Anita Lawitschka; Stefan Nierkens; Matthias Eyrich
Journal:  Front Pediatr       Date:  2022-01-11       Impact factor: 3.418

6.  Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan.

Authors:  Agnieszka Sobkowiak-Sobierajska; Caroline Lindemans; Tomas Sykora; Jacek Wachowiak; Jean-Hugues Dalle; Halvard Bonig; Andrew Gennery; Anita Lawitschka
Journal:  Front Pediatr       Date:  2022-02-18       Impact factor: 3.418
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.